Oak Street Health, Inc. (NYSE:OSH) was the recipient of some unusual options trading on Thursday. Stock investors purchased 9,581 put options on the stock. This represents an increase of approximately 1,035% compared to the average daily volume of 844 put options.
Several equities research analysts have recently commented on OSH shares. SVB Leerink lowered their target price on Oak Street Health from $51.00 to $41.00 and set a “market perform” rating for the company in a research note on Wednesday, November 10th. Morgan Stanley reissued an “equal weight” rating and issued a $33.00 target price (down from $44.00) on shares of Oak Street Health in a research note on Friday, December 17th. Zacks Investment Research raised Oak Street Health from a “sell” rating to a “hold” rating in a research note on Tuesday, October 19th. Jefferies Financial Group initiated coverage on Oak Street Health in a research note on Wednesday, October 20th. They issued a “buy” rating and a $50.00 target price for the company. Finally, Truist Securities decreased their price objective on Oak Street Health from $72.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, October 13th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $61.24.
In other Oak Street Health news, CEO Michael T. Pykosz sold 50,000 shares of Oak Street Health stock in a transaction on Tuesday, October 19th. The stock was sold at an average price of $41.82, for a total value of $2,091,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Geoffrey M. Price sold 27,500 shares of Oak Street Health stock in a transaction on Tuesday, October 12th. The shares were sold at an average price of $37.24, for a total value of $1,024,100.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 525,941 shares of company stock valued at $21,270,269. Corporate insiders own 10.10% of the company’s stock.
Several institutional investors have recently modified their holdings of OSH. Capital Research Global Investors bought a new stake in shares of Oak Street Health in the third quarter valued at about $139,805,000. Vanguard Group Inc. lifted its holdings in shares of Oak Street Health by 48.2% in the second quarter. Vanguard Group Inc. now owns 8,682,834 shares of the company’s stock valued at $508,554,000 after purchasing an additional 2,822,067 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of Oak Street Health by 34.0% in the third quarter. BlackRock Inc. now owns 7,308,774 shares of the company’s stock valued at $310,841,000 after purchasing an additional 1,854,780 shares in the last quarter. Nuveen Asset Management LLC lifted its holdings in shares of Oak Street Health by 94.7% in the second quarter. Nuveen Asset Management LLC now owns 3,123,370 shares of the company’s stock valued at $182,936,000 after purchasing an additional 1,519,285 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in shares of Oak Street Health by 692.8% in the third quarter. Millennium Management LLC now owns 1,481,702 shares of the company’s stock valued at $63,017,000 after purchasing an additional 1,294,810 shares in the last quarter. Institutional investors own 80.24% of the company’s stock.
OSH stock opened at $25.47 on Friday. The business’s 50-day moving average price is $34.91 and its two-hundred day moving average price is $45.88. The company has a current ratio of 2.78, a quick ratio of 2.78 and a debt-to-equity ratio of 5.88. The firm has a market cap of $6.14 billion, a PE ratio of -15.72 and a beta of 1.14. Oak Street Health has a 1-year low of $25.12 and a 1-year high of $66.31.
Oak Street Health (NYSE:OSH) last posted its earnings results on Monday, November 8th. The company reported ($0.49) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.47) by ($0.02). The business had revenue of $388.70 million for the quarter, compared to the consensus estimate of $357.53 million. Oak Street Health had a negative return on equity of 133.13% and a negative net margin of 27.80%. The business’s revenue was up 78.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.15) earnings per share. On average, analysts forecast that Oak Street Health will post -1.83 earnings per share for the current year.
Oak Street Health Company Profile
Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.
Read More: Diversification Important in Investing
Want More Great Investing Ideas?